🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/07/2009 | 26,46 | 26,71 | 25,74 | 25,77 | -3,71% | 3,64% | 15.229.012 |
| 01/07/2009 | 26,81 | 26,93 | 26,50 | 26,77 | +0,32% | 1,60% | 16.136.475 |
| 30/06/2009 | 26,57 | 26,77 | 26,04 | 26,68 | +0,40% | 2,73% | 22.760.254 |
| 29/06/2009 | 25,82 | 26,67 | 25,64 | 26,57 | +3,15% | 3,99% | 23.050.026 |
| 26/06/2009 | 25,27 | 25,82 | 25,13 | 25,76 | +1,62% | 2,72% | 23.773.356 |
| 25/06/2009 | 24,32 | 25,38 | 24,04 | 25,35 | +4,40% | 5,53% | 21.087.332 |
| 24/06/2009 | 24,00 | 24,49 | 23,90 | 24,28 | +1,35% | 2,47% | 15.980.742 |
| 23/06/2009 | 24,12 | 24,32 | 23,86 | 23,96 | -0,28% | 1,94% | 14.780.782 |
| 22/06/2009 | 24,56 | 24,56 | 24,00 | 24,03 | -2,82% | 2,29% | 19.518.790 |
| 19/06/2009 | 24,72 | 25,32 | 24,63 | 24,72 | +1,01% | 2,82% | 27.901.009 |
| 18/06/2009 | 23,86 | 24,72 | 23,74 | 24,48 | +3,55% | 4,12% | 21.459.058 |
| 17/06/2009 | 23,33 | 23,84 | 23,31 | 23,64 | +1,39% | 2,25% | 24.599.704 |
| 16/06/2009 | 23,86 | 24,05 | 23,25 | 23,31 | -2,12% | 3,32% | 28.060.305 |
| 15/06/2009 | 24,65 | 24,81 | 23,65 | 23,82 | -4,29% | 4,68% | 28.282.586 |
| 12/06/2009 | 24,92 | 25,83 | 24,50 | 24,89 | -0,42% | 5,32% | 31.199.170 |
| 11/06/2009 | 24,51 | 25,35 | 24,51 | 24,99 | +2,35% | 3,43% | 17.891.037 |
| 10/06/2009 | 24,73 | 24,93 | 24,25 | 24,42 | -0,51% | 2,78% | 13.460.198 |
| 09/06/2009 | 24,74 | 24,93 | 24,37 | 24,54 | -0,81% | 2,28% | 12.226.702 |
| 08/06/2009 | 24,68 | 24,98 | 24,31 | 24,74 | -0,54% | 2,71% | 18.534.299 |
| 05/06/2009 | 25,51 | 25,67 | 24,45 | 24,88 | -1,92% | 4,79% | 26.622.763 |
| 04/06/2009 | 26,21 | 26,29 | 25,26 | 25,36 | -3,66% | 3,93% | 23.123.806 |
| 03/06/2009 | 26,14 | 26,35 | 25,82 | 26,33 | -0,40% | 2,01% | 20.421.014 |
| 02/06/2009 | 26,25 | 26,59 | 25,95 | 26,43 | +0,62% | 2,44% | 15.295.560 |
| 01/06/2009 | 26,44 | 26,57 | 25,89 | 26,27 | -0,18% | 2,60% | 21.212.673 |
| 29/05/2009 | 25,71 | 26,35 | 25,62 | 26,32 | +3,03% | 2,82% | 43.884.581 |
| 28/05/2009 | 25,20 | 25,76 | 25,14 | 25,54 | +0,53% | 2,46% | 29.002.981 |
| 27/05/2009 | 25,26 | 25,57 | 25,26 | 25,41 | +0,26% | 1,25% | 20.609.549 |
| 26/05/2009 | 24,81 | 25,38 | 24,48 | 25,34 | +1,49% | 3,62% | 16.681.330 |
| 22/05/2009 | 24,95 | 25,14 | 24,78 | 24,97 | +0,19% | 1,45% | 15.340.100 |
| 21/05/2009 | 24,55 | 24,99 | 24,25 | 24,92 | +0,12% | 3,03% | 23.725.567 |